About Naveen Singh, Ph.D.
Assistant Professor, Genetics
Dr. Singh obtained his Bachelor of Science degree and Master's degree from Acharya Nagarjuna University in Guntur, Andhra Pradesh, India. He earned his PhD in genetics from New Mexico State University in Las Cruces, N.M.
Dr. Singh has vast educational experience, having worked at several higher education institutions, including New Mexico Highlands University, Indiana University School of Medicine and UT Southwestern Medical Center.
Courses Teaching:
- Genetics
- Preclinical courses
Professional Affiliations and Awards:
- Society of Toxicology (SOT)
- American Society for Biochemistry and Molecular Biology (ASBMB)
- American Chemical Society (ACS)
- American Association for Cancer Research (AACR)
Community Attributes:
- Community Outreach
- MCAT Preparation
- Interview Committee
Research/Areas of Interest:
- Studying Phase-I and Phase-II drug metabolizing enzymes, Exploiting DNA repair mechanism, Metabolism and biochemical pathways for potential anti-cancer therapy.
Recent Publications:
- Naveen Singh, Joshua E. Lewis, Reetta J. Holmila, Baran D. Sumer, Noelle S. Williams, Cristina M. Furdui, Melissa L. Kemp, David A. Boothman. Targeting NAD+ metabolism to enhance radiation therapy responses. Seminars in Radiation Oncology, Elsevier: 2019; pp 6-15.
- Edward A. Motea, X. H., Naveen Singh, Jessica A Kilgore, Noelle S. Williams, Xian-Jin Xie, David E. Gerber, Muhammad Beg, Erik A. Bey; Boothman, D. A., NQO1-dependent, tumor-selective radiosensitization of non-small cell lung cancers. Clinical Cancer Research 2019.
- Kahanda D, Singh N, Boothman DA, Slinker JD. Following anticancer drug activity in cell lysates with DNA devices. Biosens Bioelectron. 2018 Jul 30;119:1-9.
- Chen X, Mims J, Huang X, Singh N, Motea EA, Planchon SM, Beg M, Tsang AW, Porosnicu M, Kemp ML, Boothman DA, Furdui C. Modulators of Redox Metabolism in Head and Neck Cancer. Antioxid Redox Signal. 2017
- Lyday RW, Etters MA, Kim C, Magana F, Pontipiedra GM, Singh N and Kadavakollu S*, PDE5 Inhibitors Offer Novel Mechanisms in Combination and Solo Cancer Therapy, Current Cancer Therapy Reviews, 2017.